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Background: Cardiovascular diseases and cancer are jointly responsible for more than half all deaths in Portugal.
They also share some important risk factors and act as mutual competing risks. We aimed firstly to describe time
trends in death rates and years of life lost due to cardiovascular diseases and cancer in the Portuguese population
from 1980 to 2010; and secondly to quantify the contribution of the variation in population and age structure, and
age-independent “risk” by cardiovascular or oncological causes to the change in the corresponding number of
deaths.
Methods: We estimated the annual percent change in age-standardized mortality rates from cardiovascular
diseases and cancer, in each sex. The specific contribution of demographic changes (due to changes in population
size and in population age structure) and the variation in the age-independent “risk” of dying from the disease to
the observed trends in the number of deaths was quantified using the tool RiskDiff. Years of life lost were
computed using the Global Burden of Disease method.
Results: Among men, the mortality rate from all cardiovascular diseases was more than two-fold higher than
cancer mortality in 1980. However, three decades later mortality from cancer surpassed cardiovascular diseases.
After 2005, the years of life lost from cancer were also higher than from cardiovascular diseases. Among women,
despite the decrease in death rates, cardiovascular diseases remained the leading cause of death in 2010 and their
absolute burden was higher than that of cancers across the whole period, mainly due to more events in older
women.
Conclusions: In Portugal, the 20th century witnessed a dramatic decrease in the cardiovascular disease mortality
and YLL, and the transition towards cancer. In more recent years, the highest burdens of disease came from
cancers in men and from cardiovascular diseases in women.
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In 2004, cardiovascular diseases (CVD) were the leading
cause of death in the world, responsible for approxi-
mately 32% of all deaths in women and 27% in men.
After infectious and parasitic diseases, cancer ranked
third, causing some 12% of all deaths among women and
13% among men [1]. Taking the age at death into ac-
count, however, CVD were responsible for only 14% and
cancer for 8% of the total years of life lost (YLL) in* Correspondence: martasfp@med.up.pt
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Age-standardized mortality rates from CVD have been
declining for several decades in Europe [2,3], while the
downward trend in mortality from some common can-
cers is more recent, and varies with the type of cancer.
The overall cancer mortality has been decreasing less
steeply, and in some Eastern European countries is still
increasing [4]. While the proportion of all deaths from
CVD was almost three-fold higher than from cancer in
Europe, the YLL were less than two-fold higher for CVD
than cancer, in 2004 [1,5].
In Portugal, CVD were the leading cause of death in
2006, followed by cancer, and these two groups ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Portugal is characterized by a very higher contribution of cere-
brovascular disease to mortality relative to coronary heart dis-
ease [1] and long-standing higher systolic blood pressure, as
compared to most other European countries [7]. The types of
cancers that cause more deaths in Portugal are lung and stom-
ach among men and breast among women [4]. The relatively
early stage of Portugal in the smoking epidemic results in an
expected increase in the smoking-related burden of disease
and deaths, particularly among women [8,9].
We aimed to describe time trends in the absolute number
of deaths, death rates and YLL from CVD and cancer in the
Portuguese population, during the period 1980–2010, and
to quantify the contribution of the variation in the popula-
tion’s size and age structure, and age-independent “risk” of
death by cardiovascular or oncological causes to the change
in the corresponding number of deaths.Methods
Sources of data
The number of deaths from all CVD [International Clas-
sification of Diseases 10th revision (ICD 10): I00-I99; 9th
revision (ICD 9): 390–459] and all malignant neoplasms,
hereafter just referred as cancer (ICD 10: C00-C99; ICD
9: 140–239), as well as the estimates of the population at
risk in each year, were obtained from official statistics
[10,11].
All data were obtained from 1980 to 2010 for each sex
in age groups (<1, 1–4, 5-year age groups up to 80–84
and ≥85 years).Trends in mortality rates and years of life lost
Standardized mortality rates were computed by the dir-
ect method using the European standard population as
reference [12]. We performed a joinpoint regression ana-
lysis, using JoinpointW version 3.4 from the Surveillance
Research Program of the US National Cancer Institute
[13], to calculate the annual variation in mortality and to
identify points of significant change in the log-linear
slope of the trend (joinpoints) [14]. The analysis starts
with the minimum number of joinpoints (no joinpoints
corresponds to a straight line), and tests whether one or
more joinpoints significantly improve model fit. The
minimum number of observations from a joinpoint to
the earliest or the latest years and between two join-
points was set to 5. We present the results of best fitting
models for the trends in men and women. The estimated
annual percent change (APC) in mortality for each
period was calculated assuming a Poisson distribution
and taking the calendar year as the independent variable.
The analyses of the trends in the mortality rates and
numbers of deaths were performed for all ages and by
age groups (0–14, 15–34, 35–54, 55–74 and ≥75 years).The YLL due to premature mortality for each cause
(CVD and cancer), gender and age group were com-
puted using the Global Burden of Disease method [15]
by multiplying the number of deaths at each age by the
life expectancy at the age at which death occurs. We
considered the recommended standard life expectancy at
birth of 80 years for men and 82.5 for women. The aver-
age age at death was set to the mid-point of each five-
year age group, apart from the infant deaths (where it is
assumed to be 0.1 years in low mortality countries), the
1–4 year age group (assumed to be 2.6 years) and the
oldest group (assumed to be 87.5 years) [15]. We applied
a 3% time discount rate to assign less weight to the YLL
corresponding to the periods more distant to the mo-
ment of death than to those referring to the first years
after death, an age-weighting parameter to weigh YLL in
very young and old ages less than other ages (Global
Burden of Disease standard value is 0.04) and an age-
weighting correction constant so that the introduction
of age-weights did not alter the total number of YLL
(Global Burden of Disease standard value is 0.1658) [15].
The total YLL for each cause and gender was obtained
by adding the YLL of all age groups.
Contribution of changes in demographics and
age-independent “risk”
We used the tool RiskDiff, a web-based application from
the Catalan Institute of Oncology to assess the specific
contribution of demographic changes (due to changes in
population size and in population age structure) and the
variation in the age-independent “risk” of dying from the
disease to the observed trends in the number of deaths
[16]. This analysis was performed for the periods with
constant log-linear trend identified in the joinpoint ana-
lysis. RiskDiff outputs the results over an entire time
period. To allow comparisons among intervals of differ-
ent length, we estimated annual effects assuming geo-
metric change over time [17].
Results
Trends in mortality rates and years of life lost
Among men, the age-adjusted mortality from CVD
decreased between 1980 and 2010 (Figure 1 and Table 1).
The decrease was more pronounced after 1993, with an
APC of −4% per year versus −1.5% per year between
1980 and 1993. The age-adjusted mortality rate from
cancers increased 0.9% per year between 1980 and 1997,
then declined slightly, 0.7% per year, until 2006 and
increased 1.5% per year thereafter, in men. Among
women, the pattern of the age-adjusted mortality from
CVD was similar to that of men, decreasing between
1980 and 2010, more pronouncedly after 1996, reaching
an APC of −4.6% per year. The mortality rate from can-
cer increased from 1980 to 1990, then decreased slightly
Figure 1 Time trends in cardiovascular diseases and cancer 1980–2010, by sex: age-standardized (European population) mortality
rates, number of deaths and years of life lost.
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per year), and then increased 1.3% per year until 2010.
Among men, in 1980 the mortality rate from CVD
was more than two-fold higher than that from cancer,
but in 2008 the mortality rate from cancer surpassed the
mortality rate from CVD, due to opposite trends be-
tween the two groups of diseases since the mid-2000s
(Figure 1 and Table 1); the total number of deaths from
CVD was higher than from cancer between 1980 and
2010, but converged to around 15000 deaths each in
2010. Among women, despite the convergence in the
mortality rates from both diseases, CVD remained the
leading cause of death in 2010. Between 1980 and 2010,
the burden of CVD was much higher compared to can-
cer and, in 2010, CVD were responsible for 10,000
deaths more than cancers.
Among men, the YLL from cancer increased between
1980 and 2010, while the YLL from CVD decreased,mainly after the mid-1990s (Figure 1); in 2005, the YLL
from cancer surpassed those from CVD and were clearly
higher thereafter. Among women, the trends in YLL
from CVD and cancer were very similar to those
observed for mortality rates.
When analyzing trends by age groups, the mortality
rate from CVD decreased between 1980 and 2010, for
all age groups among men, while a decrease in the mor-
tality rates from cancer was only observed for the
younger age groups (up to 35 years) (Figure 2). Cancer
was a cause of death more frequently than CVD among
those under 35 years of age between 1980 and 2010, in
the last two decades for those aged 35 to 54 years and in
the last decade for those aged 55 to 74 years. Cardiovas-
cular diseases were the main of these two causes of
death from 1980 to 2010 among men aged over 75 years.
Among women, the mortality rate from CVD decreased
between 1980 and 2010 in all age groups, while mortality
Table 1 Annual change and contribution of demographic changes and age-independent “risk” to cardiovascular
diseases and cancer mortality 1980–2010, by sex
Disease
Period *
Annual change in Annual variation in number of deaths due to variation in
Age-standardized mortality











1980-1993 −1.5 (−2.0 to −1.0) 1.00 0.15 2.08 −1.59
1993-2010 −4.3 (−4.7 to −3.9) −2.20 0.18 1.35 −5.26
All cancers
1980-1997 0.9 (0.7 to 1.1) 2.76 0.28 1.65 1.16
1997-2006 −0.7 (−1.2 to −0.2) 1.18 0.60 1.32 −0.78
2006-2010 1.5 (0.2 to 2.9) 2.85 −0.26 0.66 2.47
Women All cardiovascular
diseases
1980-1996 −2.0 (−2.3 to −1.6) 0.75 0.17 1.98 −1.94
1996-2010 −4.6 (−5.1 to −4.2) −1.79 0.23 2.00 −5.92
All cancers
1980-1990 0.4 (0.2 to 0.7) 2.09 0.18 1.36 0.65
1990-2002 −0.6 (−0.9 to −0.4) 1.19 0.37 1.32 −0.61
2002-2006 −1.9 (−3.4 to −0.5) −0.62 0.41 1.26 −2.39
2006-2010 1.3 (0.4 to 2.3) 3.17 −0.10 1.08 2.24
* We considered the periods with constant log-linear trend identified in the joinpoint analysis.
Pereira et al. BMC Public Health 2012, 12:1126 Page 4 of 8
http://www.biomedcentral.com/1471-2458/12/1126rates decreased in younger women, with a recent attenu-
ation for ages 35–54 years, and remained approximately
constant in the two older age groups (Figure 2). Cancer
was the main cause of death until 55 years between 1980
and 2010 and in the last decade in the age group 55–74
years, while CVD were always the main cause of death
in women over 75 years.
Contribution of changes in demographics and
age-independent “risk”
Between 1980 and 2010, the increase in population size
and changes in the age structure towards a higher pro-
portion of older subjects contributed to an increase in
the number of deaths by CVD (around 0.2% per year
and 2% per year, respectively) (Table 1). Similarly, be-
tween 1980 and 2006, the increase of the population size
contributed to an increase in the number of cancer
deaths [between 0.2% per year in women (1980–1990)
and 0.6% per year in men (1997–2006)], as did the age-
ing of the Portuguese population (1.6% per year in men
from 1980 to 1997 and 1.3% per year in men from 1997
to 2006 and in women overall). In the period 2006–
2010, the Portuguese population decreased in number,
thereby contributing to a decrease in number of deaths
by cancer (less than 0.3% per year), while the population
ageing contributed to the change in the cancer mortality
rates by an annual variation of 0.7% in men and 1.1% in
women (Table 1).The age-independent “risk” of death from CVD
decreased between 1980 and 2010, more significantly
since the mid-1990s, after which point it translated into
a decrease in the total number of deaths of around 2%
per year. After declining for several years, the risk of
death from cancers increased by more than 2% per year
from 2006 to 2010. Overall, the number of cancer deaths
increased in both sexes between 1980 and 2010, except
for a short period between 2002 and 2006, among
women (Table 1).
Discussion
We observed a dramatic decrease in Portuguese CVD
mortality rates from 1980 to 2010 in both sexes. How-
ever, this decrease was reflected in a fall in the total
number of deaths only since the mid-1990s, due to the
increases and ageing of the population. For cancer, we
observed a much smaller decrease in the mortality rates
from the 1990s until 2006 in both sexes, and an increase
thereafter. These trends, together with increased prema-
ture mortality from cancer, meant that in men, YLL
from cancer surpassed those from CVD after 2005.
In recent years, cancer has become the leading cause
of death among men, in many other European countries,
such as France, Spain, Netherlands and Italy [18,19].
Cardiovascular diseases and cancer interact as mutually
competing risks. The observed decreasing trends in CVD
mortality may have contributed to the recent increase in
Figure 2 Time trends in cardiovascular diseases and cancer 1980–2010, by sex: mortality rates and numbers of deaths, by age groups.
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ing at risk of cancer. We also observed a decrease in the
number of deaths caused by gastro-intestinal diseases, in-
juries and poisoning, and infectious and parasitic diseases
in the last three decades, in Portugal [10]. Since some of
these causes of death are more common in the young and
middle-aged population, these trends leave more at risk
for the diseases associated with older age, such as diabetes,
CVD or cancer [20].
The mortality trends from CVD in Portugal paralleled
steady mortality declines in Western Europe, North
America, Japan and other developed areas of the world
[2,3]. This reflects decreases in both cerebrovascular and
ischaemic heart diseases, the two major contributors to
this group and more frequent in the older population
[3,21]. In Portugal, cerebrovascular disease has been the
main cause of death during the last decades [6,22]. In
developed countries, the mortality rates from stroke
have been decreasing more steeply in countries with
higher departure rates, which is the case of Portugal
[23]. This could reflect general improvements in living
conditions, lower salt consumption thanks to improved
methods for food preservation and recently, perhaps,
lower case-fatality due to stroke units and better emer-
gency care [24]. Regarding ischaemic heart disease, mod-
eling studies in many developed countries consistently
suggest that 45% to 75% of the mortality declines can be
attributed to decreases in major risk factors, with the
remaining attributable to medical and surgical treat-
ments [25-28]. In Portugal, we likewise observed notable
decreases in the mean systolic blood pressure and blood
cholesterol, smoking consumption among men, and some
dietary modifications, accompanied by the increased use
of therapies for acute coronary syndromes [7,9,29,30].
Deaths from CVD in younger age groups probably
reflected improved diagnostic capacities and successful
early surgical interventions for congenital heart disease,
plus better medical care for hypertension, cardiac arrhyth-
mias and endocarditis [31]. The pattern in the trends of
YLL suggests that death by CVD is being increasingly
delayed, clearly affecting mostly the elderly population.
Interpreting trends in cancer mortality rates can be
challenging, because they reflect trends in several com-
mon cancers. In Portugal, the specific cancers that could
particularly contribute to the slight decrease in overall
cancer mortality rate between the 1990s and 2006
among adults include stomach cancer (in both sexes),
prostate and lung among men and breast and uterus
among women [4]. Despite the trends in mortality rates,
the total number of deaths and YLL have increased
steadily. Among the more frequent cancers stomach,
lung and breast cancer are associated with death at rela-
tively younger ages [20], contributing more to the in-
crease in YLL due to cancer. On the other hand, weexpected a lower contribution to YLL from prostate can-
cer, since this is a disease mainly of the elderly popula-
tion [20]. In younger ages, the decrease in leukaemia
may also contribute [4]. The few adult cancers increas-
ing in more recent years differ between women and
men. In women, the very recent increase in breast can-
cer mortality plus the long-term increase in the lung
cancer mortality could help explain the turning point
observed in the cancer mortality rate and YLL in 2006
[32]. In men, colorectal cancer is the only common can-
cer which is increasing [10]. However, further close ana-
lyses during the forthcoming years are clearly necessary
to confirm that the trends observed in the 4 years since
2006 persist longer term. The steady decline in cancer
mortality is likely to reflect improvements in risk factors
such as male smoking and diet, compounded by better
access to earlier and specialized diagnosis, staging and
treatment [33]. Worryingly, the mortality for some can-
cers has increased since 2006, which may reflect an in-
crease exposure to other risk factors, such as obesity
[34]. The transition to a more Westernized diet has oc-
curred faster in Portugal than in some other Mediterranean
countries [35]. The continued increases in smoking among
women across the Eastern, Western and Southern parts of
Europe [36] are very concerning. Unless halted, these will
inevitably increase cancer mortality among women in Por-
tugal. Furthermore, the late implementation and the low
participation rate in organised cancer screening pro-
grammes [37] may delay the potential benefits. In 2008, the
breast and cervical cancer screening did not cover the en-
tire country and the screening program for colorectal can-
cer was still in its infancy [37]. Apart from the variation in
the population structure, we identify an increase in the risk
of dying from cancer after 2006, which inverts the previous
decrease observed in the 1990s.
The interpretation of the reported trends depends on
the quality of the source data. Misattribution or miscoding
can occur mainly because of incorrect diagnoses, incorrect
or incomplete death certificates, misinterpretation of ICD
rules for coding underlying causes, and variations in the
use of categories for unknown and ill-defined causes [38].
Like most developed countries Portuguese mortality data
have high coverage, but have been considered to have low
quality regarding the high proportion (21%) of deaths
coded as ill-defined causes [38]. Additionally, and more
specifically, there is evidence of inaccuracies in attribution
of frequent causes of death. For instance, in a validation
study in the mid-2000s, stroke was not confirmed in a
large proportion of death certificates indicating it as the
underlying cause of death, and 5% of patients were identi-
fied only after the review of death certificates [39]. The ac-
curacy in attribution to causes of death varies over time
due to quality of diagnoses and also due to changes in the
coding rules. In Portugal, two revisions of the ICD were
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ICD-10 replacing ICD-9 in 2002. However, since the ICD-
10 is more detailed than ICD-9 and we used two large
groups of diseases, without focusing on very specific
codes, errors might have been minimised.
Although we do not have information on CVD inci-
dence and case-fatality in this population, we predict that
death from CVD will be mainly associated with old age in
Portugal, as in highly developed Western European coun-
tries. However, the prevalence of CVD is likely to increase
and so is the related demand for healthcare. The observed
trends in cancer mortality highlight the importance of
primary and secondary prevention, demanding better
planning in health services, in order to obtain improve-
ments in earlier detection and/or increasing proportions
of patients receiving new or more aggressive treatment.
Conclusions
The 20th century witnessed a dramatic decrease in car-
diovascular disease mortality and YLL in Portugal and a
recent transition towards a higher burden of cancer. Fur-
thermore, the sustainability of gains against CVD is
threatened by recent trends in obesity among men and
women and increasing smoking among women. These
same risk factors play an important causal role in several
cancers, highlighting the importance of future preven-
tion strategies. This analysis of the mortality data taking
into account demographic effects, produced results that
are easily usable for policy makers. The data on the ab-
solute number of cases and demographic determinants
is potentially highly relevant for planning purposes and
also for predicting future needs.
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